Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey

OBJECTIVE Antiepileptic drugs (AEDs) are often administered prophylactically following brain tumor resection. With conflicting evidence and unestablished guidelines, however, the nature of this practice among tumor surgeons is unknown. METHODS On November 24, 2015, a REDCap (Research Electronic Data...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurosurgery 2017-06, Vol.126 (6), p.1772-1778
Hauptverfasser: Dewan, Michael C, Thompson, Reid C, Kalkanis, Steven N, Barker, 2nd, Fred G, Hadjipanayis, Constantinos G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1778
container_issue 6
container_start_page 1772
container_title Journal of neurosurgery
container_volume 126
creator Dewan, Michael C
Thompson, Reid C
Kalkanis, Steven N
Barker, 2nd, Fred G
Hadjipanayis, Constantinos G
description OBJECTIVE Antiepileptic drugs (AEDs) are often administered prophylactically following brain tumor resection. With conflicting evidence and unestablished guidelines, however, the nature of this practice among tumor surgeons is unknown. METHODS On November 24, 2015, a REDCap (Research Electronic Database Capture) survey was sent to members of the AANS/CNS Section on Tumors to query practice patterns. RESULTS Responses were received from 144 individuals, including 18.8% of board-certified neurosurgeons surveyed (across 86 institutions, 16 countries, and 5 continents). The majority reported practicing in an academic setting (85%) as a tumor specialist (71%). Sixty-three percent reported always or almost always prescribing AED prophylaxis postoperatively in patients with a supratentorial brain tumor without a prior seizure history. Meanwhile, 9% prescribed occasionally and 28% rarely prescribed AED prophylaxis. The most common agent was levetiracetam (85%). The duration of seizure prophylaxis varied widely: 25% of surgeons administered prophylaxis for 7 days, 16% for 2 weeks, 21% for 2 to 6 weeks, and 13% for longer than 6 weeks. Most surgeons (61%) believed that tumor pathology influences epileptogenicity, with high-grade glioma (39%), low-grade glioma (31%), and metastases (24%) carrying the greatest seizure risk. While the majority used prophylaxis, 62% did not believe or were unsure if prophylactic AEDs reduced seizures postoperatively. The vast majority (82%) stated that a well-designed randomized trial would help guide their future clinical decision making. CONCLUSIONS Wide knowledge and practice gaps exist regarding the frequency, duration, and setting of AED prophylaxis for seizure-naive patients undergoing brain tumor resection. Acceptance of universal practice guidelines on this topic is unlikely until higher-level evidence supporting or refuting the value of modern seizure prophylaxis is demonstrated.
doi_str_mv 10.3171/2016.4.JNS16245
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826704970</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826704970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-1cd66d293d9ffcf616624fbbcbbf6be2292f6d7438b4a194fa1182042546c7a33</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMobk6vvZNcetMtX0tb78bwkzGFzuuSpsmMtE1NUmU_wP9tyzbhwDkv5zkvnBeAa4ymFMd4RhDmUzZ9WWeYEzY_AWOcUhohntJTMEaIkIiiZD4CF95_oh5mnJyDEYkpw4glY_D75mz7sauEDEZC0QSjWlOpdlCl67ZQlLVpjA9OBGMbqG1V2R_TbGHhhGlg6GrroFNeyWF_N4xdFTy0GopeSNUEuFiss9lyncFsT8G-NsOhh75z32p3Cc60qLy6OvQJeH-43yyfotXr4_NysYok5TREWJaclySlZaq11Bzz_mldFLIoNC8UISnRvIwZTQomcMq0wDghiJE54zIWlE7A7d63dfarUz7ktfFSVZVolO183tM8RiyNUY_O9qh01nundN46Uwu3yzHKh-zzIfuc5cfs-4ubg3lX1Kr8549h0z-s84G0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826704970</pqid></control><display><type>article</type><title>Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Dewan, Michael C ; Thompson, Reid C ; Kalkanis, Steven N ; Barker, 2nd, Fred G ; Hadjipanayis, Constantinos G</creator><creatorcontrib>Dewan, Michael C ; Thompson, Reid C ; Kalkanis, Steven N ; Barker, 2nd, Fred G ; Hadjipanayis, Constantinos G</creatorcontrib><description>OBJECTIVE Antiepileptic drugs (AEDs) are often administered prophylactically following brain tumor resection. With conflicting evidence and unestablished guidelines, however, the nature of this practice among tumor surgeons is unknown. METHODS On November 24, 2015, a REDCap (Research Electronic Database Capture) survey was sent to members of the AANS/CNS Section on Tumors to query practice patterns. RESULTS Responses were received from 144 individuals, including 18.8% of board-certified neurosurgeons surveyed (across 86 institutions, 16 countries, and 5 continents). The majority reported practicing in an academic setting (85%) as a tumor specialist (71%). Sixty-three percent reported always or almost always prescribing AED prophylaxis postoperatively in patients with a supratentorial brain tumor without a prior seizure history. Meanwhile, 9% prescribed occasionally and 28% rarely prescribed AED prophylaxis. The most common agent was levetiracetam (85%). The duration of seizure prophylaxis varied widely: 25% of surgeons administered prophylaxis for 7 days, 16% for 2 weeks, 21% for 2 to 6 weeks, and 13% for longer than 6 weeks. Most surgeons (61%) believed that tumor pathology influences epileptogenicity, with high-grade glioma (39%), low-grade glioma (31%), and metastases (24%) carrying the greatest seizure risk. While the majority used prophylaxis, 62% did not believe or were unsure if prophylactic AEDs reduced seizures postoperatively. The vast majority (82%) stated that a well-designed randomized trial would help guide their future clinical decision making. CONCLUSIONS Wide knowledge and practice gaps exist regarding the frequency, duration, and setting of AED prophylaxis for seizure-naive patients undergoing brain tumor resection. Acceptance of universal practice guidelines on this topic is unlikely until higher-level evidence supporting or refuting the value of modern seizure prophylaxis is demonstrated.</description><identifier>ISSN: 0022-3085</identifier><identifier>EISSN: 1933-0693</identifier><identifier>DOI: 10.3171/2016.4.JNS16245</identifier><identifier>PMID: 27341048</identifier><language>eng</language><publisher>United States</publisher><subject>Anticonvulsants - therapeutic use ; Brain - surgery ; Brain Neoplasms - surgery ; Craniotomy ; Female ; Glioma - surgery ; Health Care Surveys ; Humans ; Male ; Neurosurgical Procedures ; Postoperative Care ; Postoperative Period ; Practice Patterns, Physicians ; Seizures - prevention &amp; control</subject><ispartof>Journal of neurosurgery, 2017-06, Vol.126 (6), p.1772-1778</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-1cd66d293d9ffcf616624fbbcbbf6be2292f6d7438b4a194fa1182042546c7a33</citedby><cites>FETCH-LOGICAL-c363t-1cd66d293d9ffcf616624fbbcbbf6be2292f6d7438b4a194fa1182042546c7a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27341048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dewan, Michael C</creatorcontrib><creatorcontrib>Thompson, Reid C</creatorcontrib><creatorcontrib>Kalkanis, Steven N</creatorcontrib><creatorcontrib>Barker, 2nd, Fred G</creatorcontrib><creatorcontrib>Hadjipanayis, Constantinos G</creatorcontrib><title>Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey</title><title>Journal of neurosurgery</title><addtitle>J Neurosurg</addtitle><description>OBJECTIVE Antiepileptic drugs (AEDs) are often administered prophylactically following brain tumor resection. With conflicting evidence and unestablished guidelines, however, the nature of this practice among tumor surgeons is unknown. METHODS On November 24, 2015, a REDCap (Research Electronic Database Capture) survey was sent to members of the AANS/CNS Section on Tumors to query practice patterns. RESULTS Responses were received from 144 individuals, including 18.8% of board-certified neurosurgeons surveyed (across 86 institutions, 16 countries, and 5 continents). The majority reported practicing in an academic setting (85%) as a tumor specialist (71%). Sixty-three percent reported always or almost always prescribing AED prophylaxis postoperatively in patients with a supratentorial brain tumor without a prior seizure history. Meanwhile, 9% prescribed occasionally and 28% rarely prescribed AED prophylaxis. The most common agent was levetiracetam (85%). The duration of seizure prophylaxis varied widely: 25% of surgeons administered prophylaxis for 7 days, 16% for 2 weeks, 21% for 2 to 6 weeks, and 13% for longer than 6 weeks. Most surgeons (61%) believed that tumor pathology influences epileptogenicity, with high-grade glioma (39%), low-grade glioma (31%), and metastases (24%) carrying the greatest seizure risk. While the majority used prophylaxis, 62% did not believe or were unsure if prophylactic AEDs reduced seizures postoperatively. The vast majority (82%) stated that a well-designed randomized trial would help guide their future clinical decision making. CONCLUSIONS Wide knowledge and practice gaps exist regarding the frequency, duration, and setting of AED prophylaxis for seizure-naive patients undergoing brain tumor resection. Acceptance of universal practice guidelines on this topic is unlikely until higher-level evidence supporting or refuting the value of modern seizure prophylaxis is demonstrated.</description><subject>Anticonvulsants - therapeutic use</subject><subject>Brain - surgery</subject><subject>Brain Neoplasms - surgery</subject><subject>Craniotomy</subject><subject>Female</subject><subject>Glioma - surgery</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Male</subject><subject>Neurosurgical Procedures</subject><subject>Postoperative Care</subject><subject>Postoperative Period</subject><subject>Practice Patterns, Physicians</subject><subject>Seizures - prevention &amp; control</subject><issn>0022-3085</issn><issn>1933-0693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMobk6vvZNcetMtX0tb78bwkzGFzuuSpsmMtE1NUmU_wP9tyzbhwDkv5zkvnBeAa4ymFMd4RhDmUzZ9WWeYEzY_AWOcUhohntJTMEaIkIiiZD4CF95_oh5mnJyDEYkpw4glY_D75mz7sauEDEZC0QSjWlOpdlCl67ZQlLVpjA9OBGMbqG1V2R_TbGHhhGlg6GrroFNeyWF_N4xdFTy0GopeSNUEuFiss9lyncFsT8G-NsOhh75z32p3Cc60qLy6OvQJeH-43yyfotXr4_NysYok5TREWJaclySlZaq11Bzz_mldFLIoNC8UISnRvIwZTQomcMq0wDghiJE54zIWlE7A7d63dfarUz7ktfFSVZVolO183tM8RiyNUY_O9qh01nundN46Uwu3yzHKh-zzIfuc5cfs-4ubg3lX1Kr8549h0z-s84G0</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Dewan, Michael C</creator><creator>Thompson, Reid C</creator><creator>Kalkanis, Steven N</creator><creator>Barker, 2nd, Fred G</creator><creator>Hadjipanayis, Constantinos G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey</title><author>Dewan, Michael C ; Thompson, Reid C ; Kalkanis, Steven N ; Barker, 2nd, Fred G ; Hadjipanayis, Constantinos G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-1cd66d293d9ffcf616624fbbcbbf6be2292f6d7438b4a194fa1182042546c7a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anticonvulsants - therapeutic use</topic><topic>Brain - surgery</topic><topic>Brain Neoplasms - surgery</topic><topic>Craniotomy</topic><topic>Female</topic><topic>Glioma - surgery</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Male</topic><topic>Neurosurgical Procedures</topic><topic>Postoperative Care</topic><topic>Postoperative Period</topic><topic>Practice Patterns, Physicians</topic><topic>Seizures - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dewan, Michael C</creatorcontrib><creatorcontrib>Thompson, Reid C</creatorcontrib><creatorcontrib>Kalkanis, Steven N</creatorcontrib><creatorcontrib>Barker, 2nd, Fred G</creatorcontrib><creatorcontrib>Hadjipanayis, Constantinos G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dewan, Michael C</au><au>Thompson, Reid C</au><au>Kalkanis, Steven N</au><au>Barker, 2nd, Fred G</au><au>Hadjipanayis, Constantinos G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey</atitle><jtitle>Journal of neurosurgery</jtitle><addtitle>J Neurosurg</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>126</volume><issue>6</issue><spage>1772</spage><epage>1778</epage><pages>1772-1778</pages><issn>0022-3085</issn><eissn>1933-0693</eissn><abstract>OBJECTIVE Antiepileptic drugs (AEDs) are often administered prophylactically following brain tumor resection. With conflicting evidence and unestablished guidelines, however, the nature of this practice among tumor surgeons is unknown. METHODS On November 24, 2015, a REDCap (Research Electronic Database Capture) survey was sent to members of the AANS/CNS Section on Tumors to query practice patterns. RESULTS Responses were received from 144 individuals, including 18.8% of board-certified neurosurgeons surveyed (across 86 institutions, 16 countries, and 5 continents). The majority reported practicing in an academic setting (85%) as a tumor specialist (71%). Sixty-three percent reported always or almost always prescribing AED prophylaxis postoperatively in patients with a supratentorial brain tumor without a prior seizure history. Meanwhile, 9% prescribed occasionally and 28% rarely prescribed AED prophylaxis. The most common agent was levetiracetam (85%). The duration of seizure prophylaxis varied widely: 25% of surgeons administered prophylaxis for 7 days, 16% for 2 weeks, 21% for 2 to 6 weeks, and 13% for longer than 6 weeks. Most surgeons (61%) believed that tumor pathology influences epileptogenicity, with high-grade glioma (39%), low-grade glioma (31%), and metastases (24%) carrying the greatest seizure risk. While the majority used prophylaxis, 62% did not believe or were unsure if prophylactic AEDs reduced seizures postoperatively. The vast majority (82%) stated that a well-designed randomized trial would help guide their future clinical decision making. CONCLUSIONS Wide knowledge and practice gaps exist regarding the frequency, duration, and setting of AED prophylaxis for seizure-naive patients undergoing brain tumor resection. Acceptance of universal practice guidelines on this topic is unlikely until higher-level evidence supporting or refuting the value of modern seizure prophylaxis is demonstrated.</abstract><cop>United States</cop><pmid>27341048</pmid><doi>10.3171/2016.4.JNS16245</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3085
ispartof Journal of neurosurgery, 2017-06, Vol.126 (6), p.1772-1778
issn 0022-3085
1933-0693
language eng
recordid cdi_proquest_miscellaneous_1826704970
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Anticonvulsants - therapeutic use
Brain - surgery
Brain Neoplasms - surgery
Craniotomy
Female
Glioma - surgery
Health Care Surveys
Humans
Male
Neurosurgical Procedures
Postoperative Care
Postoperative Period
Practice Patterns, Physicians
Seizures - prevention & control
title Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T21%3A57%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prophylactic%20antiepileptic%20drug%20administration%20following%20brain%20tumor%20resection:%20results%20of%20a%20recent%20AANS/CNS%20Section%20on%20Tumors%20survey&rft.jtitle=Journal%20of%20neurosurgery&rft.au=Dewan,%20Michael%20C&rft.date=2017-06-01&rft.volume=126&rft.issue=6&rft.spage=1772&rft.epage=1778&rft.pages=1772-1778&rft.issn=0022-3085&rft.eissn=1933-0693&rft_id=info:doi/10.3171/2016.4.JNS16245&rft_dat=%3Cproquest_cross%3E1826704970%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826704970&rft_id=info:pmid/27341048&rfr_iscdi=true